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Abstract
Objective:  Distal  renal  tubular  acidosis  (dRTA)  is  characterized  by  metabolic  acidosis  due  to
impaired  renal  acid  excretion.  The  aim  of  this  study  was  to  demonstrate  the  genetic  diagnosis
of four  children  with  dRTA  through  use  of  whole-exome  sequencing.
Methods:  Two  unrelated  families  were  selected;  a  total  of  four  children  with  dRTA  and  their
parents, in  order  to  perform  whole-exome  sequencing.  Hearing  was  preserved  in  both  children
from the  ﬁrst  family,  but  not  in  the  second,  wherein  a  twin  pair  had  severe  deafness.  Whole-
exome sequencing  was  performed  in  two  pooled  samples  and  ﬁndings  were  conﬁrmed  with
Sanger sequencing  method.
Results:  Two  mutations  were  identiﬁed  in  the  ATP6V0A4  and  ATP6V1B1  genes.  In  the  ﬁrst  fam-
ily, a  novel  mutation  in  the  exon  13  of  the  ATP6V0A4  gene  with  a  single  nucleotide  change
GAC →  TAC  (c.1232G>T)  was  found,  which  caused  a  substitution  of  aspartic  acid  to  tyrosine
in position  411.  In  the  second  family,  a  homozygous  recurrent  mutation  with  one  base-pair
insertion (c.1149  1155insC)  in  exon  12  of  the  ATP6V1B1  gene  was  detected.
Conclusion:  These  results  conﬁrm  the  value  of  whole-exome  sequencing  for  the  study  of  rare
and complex  genetic  nephropathies,  allowing  the  identiﬁcation  of  novel  and  recurrent  muta-
tions. Furthermore,  for  the  ﬁrst  time  the  application  of  this  molecular  method  in  renal  tubular
diseases has  been  clearly  demonstrated.
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Resumo
Objetivo:  A  acidose  tubular  renal  distal  (ATRd)  é  caracterizada  por  acidose  metabólica  devido
a excrec¸ão  renal  de  ácido  prejudicada.  O  objetivo  deste  artigo  é  apresentar  o  diagnóstico
genético de  quatro  crianc¸as  com  ATRd  utilizando  o  sequenciamento  total  do  exoma.
Métodos:  Selecionamos  duas  famílias  não  relacionadas,  totalizando  quatro  crianc¸as  com  ATRd
e seus  pais,  para  realizar  o  sequenciamento  total  do  exoma.  A  audic¸ão  foi  preservada  em  ambas
as crianc¸as  da  família  um,  porém  em  nenhuma  crianc¸a  da  família  dois,  na  qual  um  par  de  gêmeas
teve perda  auditiva  severa.  Realizamos  o  sequenciamento  total  do  exoma  em  dois  conjuntos  de
amostras e  conﬁrmamos  os  achados  com  o  método  de  Sequenciamento  de  Sanger.
Resultados:  Duas  mutac¸ões  foram  identiﬁcadas  nos  genes  ATP6V0A4  e  ATP6V1B1.  Na  família
um, detectamos  uma  nova  mutac¸ão  no  éxon  13  do  gene  ATP6V0A4  com  uma  alterac¸ão  em  um
nucleotídeo  único  GAC  →  TAC  (c.1232G>T)  que  causou  substituic¸ão  de  ácido  aspártico  por
tirosina na  posic¸ão  411.  Na  família  dois,  detectamos  uma  mutac¸ão  recorrente  do  homozigoto
com inserc¸ão  de  um  par  de  bases  (c.1149  1155insC)  no  éxon  12  do  gene  ATP6V1B1.
Conclusão:  Nossos  resultados  conﬁrmam  o  valor  do  sequenciamento  total  do  exoma  para  o
estudo de  nefropatias  genéticas  complexas,  permitindo  a  identiﬁcac¸ão  de  mutac¸ões  novas  e
recorrentes.  Adicionalmente,  demonstramos  claramente  pela  primeira  vez  a  aplicac¸ão  desse
método  molecular  em  doenc¸as  tubulares  renais.
© 2015  Sociedade  Brasileira  de  Pediatria.  Publicado  por  Elsevier  Editora  Ltda.  Todos  os  direitos
reservados.
I
D
p
a
c
i
t
c
c
C
p
u
a
i
c
r
o
d
d
o
t
S
b
s
c
v
n
m
a
a
d
2
a
w
e
m
o
k
g
T
p
m
t
m
p
t
w
r
t
r
o
P
S
F
i
untroduction
istal  renal  tubular  acidosis  (dRTA)  is  a  rare  and  com-
lex  renal  disease  due  to  a  defect  in  the  excretion  of
cid  load  (H+ and  ammonium  ions)  in  alpha-intercalated
ells  of  the  collecting  duct.  The  acid  load  accumulation
n  the  distal  nephron  results  in  consumption  and  reduc-
ion  of  the  bicarbonate/CO2 buffer  in  blood.1 The  main
linical  features  of  dRTA  are  vomiting,  diarrhea,  and/or
onstipation,  loss  of  appetite,  polydipsia,  and  polyuria.
hronic  acidosis  and  secondary  alterations  such  as  vomiting,
olyuria,  and  dehydration  affect  growth,  leading  to  fail-
re  to  thrive.  Ultrasound  studies  can  show  nephrocalcinosis
nd/or  nephrolithiasis.2 In  general,  dRTA  has  good  prognosis
f  it  is  diagnosed  at  an  early  age  and  alkaline  treatment  is
ontinued.  Untreated,  dRTA  causes  growth  retardation  and
ickets  in  children  and  osteomalacia  in  adults.  Deterioration
f  renal  function  can  occur  over  the  years.3
Distal  RTA  can  be  transmitted  as  either  an  autosomal
ominant  or  an  autosomal  recessive  trait.4 The  autosomal
ominant  phenotype  typically  courses  mildly  in  adolescence
r  adulthood;4 one  parent  suffers  from  and  is  the  carrier  of
he  disease,  or  it  is  due  to  de  novo  mutation.  Mutations  in  the
LC4A1  gene  in  families  with  autosomal  dominant  dRTA  have
een  identiﬁed.2,5,6 The  symptoms  in  the  autosomal  reces-
ive  phenotype  predominantly  appear  at  infancy  or  early
hildhood,  in  which  growth  retardation  is  very  common.  This
ariant  can  occur  with  or  without  deafness,  and  parents  are
ot  affected.2 Autosomal  recessive  dRTA  is  associated  with
utations  in  any  of  the  following  genes:  SLC4A1,7 ATP6V0A4,
nd  ATP6V1B1.2,8 Individuals  without  hearing  defects  usu-
lly  carry  mutations  in  the  ATP6V0A4  gene,  while  those  with
eafness  have  ATP6V1B1  gene  mutations.  In  approximately
s
1
d
T0%  of  the  patients  with  dRTA,  no  mutations  were  found  in
ny  of  these  related  genes.3 Indeed,  there  are  dRTA  patients
ith  deafness  without  ATP6V1B1  gene  mutations,  and  oth-
rs  with  normal  hearing  who  do  not  have  ATP6V0A4  gene
utations.3 These  ﬁndings  suggest  that  other  transporters
r  channels  might  cause  dRTA.  In  terms  of  complexity,  it  is
nown  that  some  patients  with  mutations  in  the  ATP6V0A4
ene  develop  deafness  only  in  the  second  decade  of  life.
hus,  there  remains  much  to  be  elucidated  in  terms  of
henotype--genotype  correlations.8--10 So  far,  more  than  20
utations  in  ATP6V0A4  are  already  known.
Whole-exome  sequencing  provides  coverage  of  more
han  95%  of  the  exons,  which  contain  85%  of  disease-causing
utations  in  Mendelian  disorders  and  many  disease-
redisposing  single  nucleotide  polymorphisms  (SNPs)
hroughout  the  genome.11,12 Whole-exome  sequencing  is
orthwhile  to  evaluate  the  disease  pathogenesis  and  to
ecognize  new  pathogenic  genes  or  mutations  associated
o  disorder,  especially  in  Mendelian  disorders.11,12 In  this
egard,  the  present  study  aimed  to  evaluate  the  usefulness
f  whole-exome  sequencing  for  genetic  diagnosis  of  dRTA.
atients and methods
ubjects  and  clinical  assessment
our  children  with  conﬁrmed  dRTA  from  two  unrelated  fam-
lies  were  selected  for  this  study.  All  patients  were  followed
p  at  the  Pediatric  Nephrology  Unit  of  the  Federal  Univer-
ity  of  Minas  Gerais  (UFMG),  Brazil.  The  ﬁrst  family  (Family
)  consisted  of  two  affected  siblings,  a  girl  and  a  boy,  with
RTA  but  without  deafness,  and  their  unaffected  parents.
he  second  family  (Family  2)  had  a  monozygotic  twin  pair
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(two  girls),  diagnosed  with  dRTA  and  nerve  deafness,  and
their  healthy  mother;  the  father  is  unknown.  All  patients
were  submitted  to  a  systematic  protocol  including  clinical
and  nutritional  evaluation,  laboratory  measurements,  renal
ultrasonography,  and  genetic  analysis.  Informed  consent,
approved  by  the  institutional  Ethics  Board  of  UFMG,  was
obtained  from  all  participants;  in  the  case  of  children,  it
was  also  obtained  from  their  parent/guardian.
DNA  extraction
Genomic  DNA  was  extracted  from  5  mL  of  dRTA  patients  and
their  parent’s  peripheral  blood,  using  a  QIAamp  Blood  DNA
mini  Kit  (Qiagen®,  Milano,  Italy)  according  to  the  manu-
facturer’s  instructions.  All  samples  were  quality  controlled
for  purity  using  a  NanoDrop  spectrophotometer  (Thermo
Scientiﬁc®,  Waltham,  USA).  DNA  samples  were  stored  at
−20 ◦C  until  usage.
Whole-exome  sequencing
Exome  sequencing  was  performed  on  two  pools  of  samples  to
optimize  the  results.  Samples  were  pooled  considering  the
clinical  features  of  the  patients.  The  ﬁrst  pool  had  DNA  from
the  two  siblings  with  dRTA  without  deafness,  and  the  second,
from  the  twin  sisters  with  dRTA  associated  with  deafness.
Array  capture  was  used  to  isolate  the  relevant  human  genes
(SeqCap  EZ  Human  Exome  Library  v2.0,  Roche®,  Basel,
Switzerland)  and  these  genes  were  sequenced  on  the  Illu-
mina  HiSeq  2000plataform  (Sigma--Aldrich  Corporation®,
Missouri,  USA).
Filtering  data
The  following  principle  steps  were  taken  to  prioritize  the
high-quality  variants:  (i)  variants  within  intergenic,  intronic,
and  untranslated  region  (UTR)  regions  and  synonymous
mutations  were  excluded  from  downstream  analysis;  (ii)
variants  with  quality  score  less  than  20  were  excluded;
(iii)  only  the  conservation  score  (phyloP)  from  comparison
of  human  and  43  vertebrates  higher  than  3  were  consid-
ered;  (iv)  after  this  prior  selection,  the  remaining  genes
were  ﬁltered  by  the  function.  The  software  PolyPhen-2
(http://genetics.bwh.harvard.edu/pph2/)  predicted  possi-
ble  impact  of  variants.  The  ﬁnal  set  of  selected  variants  was
visually  inspected  using  an  Integrative  Genomics  Viewer.13
Previously  described  polymorphic  variants  in  public  data
were  investigated  and  compared  with  the  variations  found
in  the  current  exome.  The  selected  mutations  to  be  investi-
gated  in  each  group  of  this  study  were  not  found  in  previous
exome  sequences  (http://evs.gs.washington.edu/EVS/).
Validation  of  data
Polymerase  chain  reaction  (PCR)  Sanger  sequencing  was
used  in  the  analysis  to  conﬁrm  the  data.  All  patients
and  their  parents  were  submitted  to  the  PCR.  Ampliﬁ-
cation  products  of  appropriate  size  were  identiﬁed  using
polyacrylamide  gel  electrophoresis.  Products  were  puri-
ﬁed  using  the  QIAquick  PCR  puriﬁcation  kit  (Qiagen®,
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ilano,  Italy)  and  then  submitted  to  sequencing  reac-
ion  using  both  forward  and  reverse  primers  with  the  ABI
igDye  Terminator  Cycle  Sequencing  Kit  v.  3.1  on  an  ABI
RISM  3730XL  Genetic  Analyzer  (Applied  Biosystems®,  Fos-
er  City,  USA).  Each  read  was  aligned  to  the  reference
equence,  and  mutations  were  identiﬁed  with  Sequencer
oftware  (http://www.genecodes.com).  All  primers  were
esigned  using  the  online  tool  Primer3.  The  primers  for  exon
2  of  ATP6V1B1  gene  were:  5′TTGACCCCTCGGAATGTAGG3′
nd  5′CCGGACCCTCTTCTCCTTAC3′ (product  size  of  238
ase  pairs).  The  primers  for  exon  13  of  ATP6V1B1  were:
′ATGCAAATCGTGGAGCTGTG3′ and  5′ATGAATCAGGGCAA-
ACGGT3′ (product  size  of  264  base  pairs).
tructural  studies  of  mutations
rotein  and  DNA  sequence  alignments  were  performed  using
he  ClustalW  and  the  MultAlin  (http://multalin.toulouse.
nra.fr/multalin/),  respectively.  The  prediction  of  amino
cid  substitution  on  the  biological  function  of  the  pro-
ein  was  evaluated  using  both  PolyPhen-2  and  Provean
oftware  (http://provean.jcvi.org  and  http://genetics.
wh.harvard.edu/pph2/,  respectively).
esults
RTA  without  deafness
his  family  consisted  of  two  siblings,  a  13-year-old  girl  and
er  7-year-old  brother,  with  well-deﬁned  dRTA.  The  girl  was
he  proband,  diagnosed  with  dRTA  at  the  age  of  4  months.
he  initial  ﬁndings  were  failure  to  thrive,  hyperchloremic
etabolic  acidosis  with  abnormally  high  urine  pH  (7.0),  nor-
al  venous  blood  pH  (7.36),  normal  glomerular  ﬁltration
ate,  and  nephrocalciosis.  The  boy  was  diagnosed  in  his  1st
onth  of  life,  after  a  severe  dehydration  with  metabolic
cidosis,  hypokalemia,  transient  elevation  of  serum  cre-
tinine,  and  hypocalcemia.  His  ﬁrst  renal  ultrasonography
howed  bilateral  nephrocalcinosis.  Table  1  summarizes  clin-
cal  and  biochemical  manifestations  at  baseline  leading  to
he  diagnosis  of  dRTA  in  each  patient.  The  parents  were
naffected,  and  had  an  older  child  that  died  by  the  age  of  4
onths  with  similar  symptoms.
Whole-exome  sequencing  conducted  in  this  group  gener-
ted  3577  single  nucleotide  variations  (SNVs)  and  416  small
nsertions  and  deletions  (INDELs).  Filtering  for  variants  was
pplied  to  select  the  candidate  gene  (Table  2).
After  ﬁltering  the  exome  data,  the  ATP6V0A4  gene  was
elected  for  study.  A  single  nucleotide  change  GAC  →  TAC
c.1232G>T)  in  exon  13  was  observed,  which  caused  an
mino  acid  substitution:  aspartic  acid  to  tyrosine  in  posi-
ion  411  (p.D411Y).  This  amino  acid  change  was  predicted
o  be  damaging  by  Provean  and  PolyPhen-2.  This  mutation
ccurs  at  an  evolutionarily  conserved  amino  acid  and  affects
ighly  preserved  residues  (data  not  shown).
The  patients  and  their  parents  were  submitted  to  Sanger
equencing  by  using  the  designed  primer  for  exon  13  of  the
TP6V0A4  gene.  The  two  siblings  presented  the  same  muta-
ion  in  homozygosis  (c.1232G>T),  while  both  parents  had  a
eterozygous  trace  (Fig.  1A  and  B).  This  is  a  novel  autosomal
ecessive  dRTA  mutation.
586  Pereira  PC  et  al.
Table  1  Clinical  and  biochemical  ﬁndings  at  baseline  of  patients  with  dRTA.
Findings/patients  II2  --  Family  1  II3  --  Family  1  II1  --  Family  2  II2  --  Family  2
Age  4  months  1  month  2  years  2  years
Sex Female  Male  Female  Female
Deafness/SNHL  Absent  Absent  Present  Present
Birth weight  (g)  Not  available  3450  2340  2300
Weight (g)  3960  3760  8250  8300
WAZ <−3  0  <−3  <−3
Height (cm)  54.5  50.0  73.5  74.0
HAZ <−3  −2  <−3  <−3
Nephrocalcinosis  Present  Present  Absent  Absent
Initial manifestations Failure  to  thrive,
dehydration
Vomiting  and
dehydration
Rickets,  failure  to
thrive,  growth
retardation
Rickets,  failure  to
thrive,  growth
retardation
Serum creatinine  (mg/dL)  0.4  1.7  0.5  0.5
Blood venous  pH  7.36  7.16  7.23  7.12
Serum bicarbonate  (mmol/L)  19.0  8.0  15.9  13.7
Serum potassium  (mEq/L) 3.8  2.0  4.0  4.1
Serum chloride  (mmol/L) 109  118  117  123
Urinary pH 7.5  7.1  7.0  7.0
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wRoman numerals indicate the family position on the pedigree: II2
Family 1 refers to the third proband (son) of family one; II1, Fami
twin daughter; SNHL, sensorineural hearing loss; WAZ, weight-for
RTA  with  deafness
his  family  consisted  of  a  twin  pair  of  girls  with  dRTA  in
ssociation  with  nerve  deafness.  The  girls  were  diagnosed
t  the  age  of  2  after  a  long  period  of  treating  for  rickets  and
rowth  retardation  with  only  nutritional  support.  Clinical
nd  biochemical  features  at  baseline  are  shown  in  Table  1.
Whole-exome  sequencing  conducted  in  the  family  two
enerated  4375  SNVs  and  2416  INDELs.  After  ﬁltering  the
ariants,  only  one  candidate  gene  remained  (Table  2).
Based  on  the  exome  data,  the  ATP6V1B1  gene  was
elected  as  the  candidate  in  this  group.  A  homozygous
ne  base-pair  insertion  (c.1149  1155insC)  in  exon  12  was
etected  (Fig.  2A).  The  two  dRTA  twin  sisters  presented
he  insertion  described.  PCR  of  their  unaffected  mother
as  performed  (father  unknown).  The  two  siblings  had  the
ame  homozygous  mutation,  while  the  mother  presented
his  insertion  in  heterozygosis  (Fig.  2B  and  C).
w
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Table  2  Variant  prioritizing  for  Family  1  and  for  Family  2.
Parameters  
Total  variants  
Intergenic, intronic,  and  UTR  regions  and
synonymous  mutations  were  excluded
Quality score  <20  were  excluded  
PhyloP <3  were  excluded  
Selection by  function
PolyPhen <0.7  were  excluded
Selection using  cross-reference  gene  database  and
IGV
Candidate gene  
UTR, untranslated region.ily 1 refers to the second proband (daughter) of family one; II3,
- the ﬁrst twin daughter of family two; II2, Family 2 -- the second
z-score; HAZ, height-for-age z-score.
iscussion
everal  DNA  errors  are  located  in  exons  leading  to  struc-
ural  alterations  in  proteins  and  functional  changes.3 In
his  manner,  whole-exome  analyzes  these  exons  in  a  rapid
nd  cost-effective  manner,  allowing  genetic  evaluation  of
omplex  and  monogenic  diseases.14,15 In  rare  disorders,  the
se  of  whole-exome  may  minimize  the  failure  in  detecting
utations  at  hot-spots  regions.  Nonetheless,  direct  Sanger
equencing  is  still  considered  the  most  accurate  method  to
nd  mutations,  since  other  gene  testing  techniques,  such  as
hole  exome,  may  not  detect  all  sequence  variations.  The
earch  in  a  whole-genome  basis  and  validation  of  ﬁndings
ith  Sanger  sequencing  method  appears  to  be  an  efﬁcient
ay  to  determine  genetic  causality  of  a disorder.  However,
he  incorporation  of  these  next-generation  technologies
nto  clinical  practice  is  still  challenging,  since  these  tech-
iques  are  remain  very  expensive,  and  data  interpretation
Family  1  Family  2
Number  of  variants  Number  of  variants
3993  6791
1445  1912
879  1012
131  215
15  14
10  6
1  1
1  1
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A
l:1
ll:1 ll:2 ll:3
l:2 WT
T T T TG G ∗ GA A C
I.1
I.2
II.2
II.3
B
Figure  1  Identiﬁcation,  pedigree  of  Family  1,  and  results  of  sequencing  for  c.1232G>T  mutation.  (A)  The  pedigree  shows  the
affected statuses,  individual  identiﬁers,  and  genotypes  at  codon  411.  The  arrow  indicates  the  proband.  (B)  DNA  sequence  chro-
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vmatograms in  which  the  two  affected  siblings  have  homozygous  G
in both  parents.  WT,  wild  type.  *Mutated  nucleotide.
is  laborious  and  difﬁcult.11,12 Recent  studies  suggest  that
whole-exome  sequencing  would  be  useful  to  evaluate  dis-
ease  pathogenesis  and  to  recognize  new  pathogenic  genes
or  mutations  associated  to  disorder,  special  in  Mendelian
disorders.16 Thus,  the  present  study  used  whole  exome
followed  by  Sanger  sequencing  as  a  strategy  for  genetic
diagnosis  of  dRTA  in  four  children.These  results  showed,  for  the  ﬁrst  time,  the  utility
of  whole-exome  sequencing  in  renal  tubular  disorders,
by  allowing  the  identiﬁcation  of  a  recurrent  and  a  new
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Figure  2  Identiﬁcation,  pedigree  of  Family  2,  and  results  of  sequ
the c.1149  1155insC  mutation  using  MultAlin.  (B)  The  pedigree  show
at c.1149-1155insC.  The  arrow  indicates  the  probands  and  the  ind
sequence chromatograms  of  family  members,  in  which  the  two  affe
has a  heterozygous  trace,  as  marked  by  the  red  box.  WT,  wild  type. substitution  at  c.1232.  This  substitution  occurs  in  heterozygosis
athogenic  mutation  in  dRTA.  Inherited  forms  of  dRTA  have
hree  variants:  autosomal  dominant  and  autosomal  reces-
ive,  with  or  without  deafness.4 Dominant  disease  typically
resents  more  mildly  in  adolescence  or  adulthood,  and
t  has  been  only  associated  to  mutations  in  the  bicar-
onate/chloride  exchanger  (AE1).  However,  the  recessive
ariant  occurs  in  infancy  or  early  childhood,  in  which  growth
etardation  is  very  common,4 as  observed  in  the  present
ases.  Autosomal  recessive  dRTA  has  been  associated  with
utations  in  the  genes  ATP6V1B1  and  ATP6V0A4, which
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encing  for  the  c.1149  1155insC  mutation.  (A)  Identiﬁcation  of
s  the  affection  statuses,  individual  identiﬁers,  and  genotypes
ividual  with  ‘‘?h¨as  uncertain  genotype  status.  (C)  Direct  DNA
cted  siblings  have  homozygous  insertion  of  a  C  and  the  mother
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ncode  the  subunits  a4  and  B1  of  the  vacuolar-type  pro-
on  ATPase  (V-  or  H+-ATPase),  respectively.17--22 In  addition,
utations  in  the  SLC4A1  gene,  responsible  for  the  expres-
ion  of  AE1  proteins,  have  been  also  detected  in  cases  of
utosomal  recessive  dRTA  without  deafness.23--28
Indeed,  mutations  in  different  subunits  of  the  proton
ump  that  are  expressed  in  kidney  and  ear  tissues  can  cause
ubular  defects  associated  with  deafness.17 The  vacuolar-
ype  proton  ATPase  (V-  or  H+-ATPase)  is  a  pump  with
ultiple  subunits  that  is  essential  for  normal  acidiﬁcation.
wo  structural  domains  form  this  pump:  membrane-bound
0  and  cytoplasmic  or  peripheral  V1.  Each  domain  com-
rises  multiple  subunits  (a--e  and  A--H,  respectively),  which
re  responsible  for  ATP  hydrolysis  and  proton  transport,
espectively.4 The  ATP6V1B1  gene  encodes  the  B1  sub-
nit,  while  the  ATP6V0A4  gene  encodes  the  a4  subunit.
he  vacuolar-type  proton  ATPase  is  expressed  apically  on
enal  -intercalated  cells,  and  in  the  cochlea  and  endolym-
hatic  sac.  Based  on  the  type  of  hearing  loss,  these  types
f  mutations  can  be  suspected.  Conductive  deafness  was
bserved  in  mutations  of  the  intracellular  isoform  of  car-
onic  anidrase  (CA),  whereas  sensorineural  hearing  loss
SNHL)  has  been  associated  with  ATP6V1B1  and  ATP6V0A4
utations.18--20 Accordingly,  a  homozygous  one  base-pair
nsertion  (c.1149 1155insC)  was  found  in  exon  12  of  the
TP6V1B1  gene  in  twin  sisters  with  SNHL.  Mutations  in
he  SLC4A1  gene  usually  do  not  have  any  association  with
eafness.22--28 Therefore,  the  presence  and  the  kind  of  deaf-
ess  are  helpful  in  distinguishing  different  forms  of  dRTA.
In  the  two  families  of  this  study,  parents  were  unaffected
nd  dRTA  had  early  onset,  leading  to  growth  impairment
uring  infancy.  Therefore,  mutations  in  the  SLC4A1  gene
AE1  proteins)  were  highly  unlikely  in  the  patients.  In  Family
,  exome  sequencing  identiﬁed  a  novel  homozygous  muta-
ion  in  the  ATP6V0A4  gene.  Based  on  previous  reports10
nd  on  the  clinical  and  biochemical  features,  this  gene  was
elected  as  a  potential  candidate  to  search  for  mutations,
ince  no  hearing  loss  was  detected  in  the  affected  patients.
 single  nucleotide  change  in  exon  13  was  observed  that
aused  an  amino  acid  substitution:  aspartic  acid  to  tyro-
ine  in  position  411.  This  aminoacid  change  was  predicted
o  be  damaging  by  Provean  and  PolyPhen-2.  Unfortunately,
o  functional  studies  were  performed  to  decipher  the  pre-
ise  role  of  this  mutation.  However,  it  should  be  mentioned
hat  this  mutation  occurs  at  an  evolutionarily  conserved
minoacid  and  affects  highly  preserved  residues.  In  addi-
ion,  the  substitution  of  aspartic  acid  by  tyrosine  may  change
hemical  properties  of  the  protein  at  critical  regions.  For
nstance,  this  change  may  alter  the  isoelectric  point  of  the
rotein,  considering  that  tyrosine  is  a  neutral  aminoacid,
hile  aspartic  acid  is  an  acid.
The  twin  girls  of  family  two  had  SNHL  and  early-onset
ymptoms  of  dRTA.  The  phenotypes,  together  with  the
hole-exome  data,  led  the  authors  to  investigate  the
TP6V1B1  gene.  Accordingly,  a  previously  described  muta-
ion  was  found,9 which  was  also  conﬁrmed  by  Sanger
equencing.  It  should  be  pointed,  however,  that  ATP6V1B1  or
TP6V0A4  gene  mutations  have  not  been  not  found  in  some
amilies  with  primary  recessive  forms  of  dRTA.  There  are
umerous  other  candidate  genes  for  recessive  dRTA,29 espe-
ially  those  genes  related  to  the  proton  transporters.  In  this
egard,  the  use  of  whole-exome  sequencing  together  with
1Pereira  PC  et  al.
he  phenotype  characteristics  may  result  in  the  discovery  of
ew  mutations  and  genetic  alterations  in  this  complex  and
are  disease.
In  summary,  whole-exome  sequencing  followed  by  Sanger
equencing  was  a successful  strategy  in  identifying  novel  and
ecurrent  mutations  in  these  cases  of  dRTA.  However,  which
enetic  variants  are  potentially  causative  of  renal  tubular
ransport  alterations  remains  to  be  elucidated,  especially  in
ecessive  forms  dRTA.
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